MEI Pharma, Inc. Quarterly Costs and Expenses in USD from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
MEI Pharma, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2015 to Q2 2024.
  • MEI Pharma, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $19M, a 51.4% increase year-over-year.
  • MEI Pharma, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $50.8M, a 40.7% decline year-over-year.
  • MEI Pharma, Inc. annual Costs and Expenses for 2024 was $50.8M, a 40.7% decline from 2023.
  • MEI Pharma, Inc. annual Costs and Expenses for 2023 was $85.6M, a 26.3% decline from 2022.
  • MEI Pharma, Inc. annual Costs and Expenses for 2022 was $116M, a 22% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $50.8M $19M +$6.44M +51.4% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-19
Q1 2024 $44.3M $9.83M -$12.5M -55.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $56.8M $11.9M -$11.9M -49.9% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $68.6M $10M -$16.9M -62.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $85.6M $12.5M -$15.1M -54.6% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-19
Q1 2023 $101M $22.3M -$8.97M -28.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $110M $23.8M -$5.65M -19.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $115M $26.9M -$913K -3.28% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $116M $27.6M +$4.68M +20.4% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-26
Q1 2022 $111M $31.3M +$6.75M +27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $105M $29.5M +$1.09M +3.84% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 $104M $27.9M +$8.44M +43.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $95.2M $22.9M +$10.1M +78.2% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-08
Q1 2021 $85.2M $24.5M +$10.8M +79% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $74.3M $28.4M +$15.3M +116% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-05-23
Q3 2020 $59.1M $19.4M +$5.64M +40.9% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-23
Q2 2020 $53.5M $12.9M -$9K -0.07% Apr 1, 2020 Jun 30, 2020 10-K 2022-09-08
Q1 2020 $53.5M $13.7M -$178K -1.28% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $53.6M $13.1M -$779K -5.61% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $54.4M $13.8M +$3.26M +31% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $51.2M $12.9M +$4.86M +60.6% Apr 1, 2019 Jun 30, 2019 10-K/A 2022-05-23
Q1 2019 $46.3M $13.9M +$7.38M +114% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $38.9M $13.9M +$7.37M +113% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $31.6M $10.5M +$1.35M +14.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $30.2M $8.02M +$3.13M +64.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-09-09
Q1 2018 $27.1M $6.49M +$1.31M +25.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $25.8M $6.53M +$1.15M +21.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $24.6M $9.17M +$3.75M +69.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $20.9M $4.89M -$934K -16% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-28
Q1 2017 $21.8M $5.18M -$235K -4.34% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $22M $5.38M +$256K +4.99% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 $21.8M $5.42M +$774K +16.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $21M $5.82M Apr 1, 2016 Jun 30, 2016 10-K 2018-08-30
Q1 2016 $5.41M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $5.13M Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $4.65M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.